RxDoctor Payments Data

Jaclyn Herbst, APRN

Adult Health · Deland, FLNPI 1174276877

Payments from drug & device makers

$1,122in general payments, 2019–2025

Across 47 payments — averaging $23.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$231
  • Bayer$185
  • Otsuka America Pharmaceutical, Inc.$167
  • Novo Nordisk$114
  • AstraZeneca$71
  • Lundbeck LLC$71
  • plus $283 from 7 others

What the payments were for

  • Food & beverage$1,122100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,122 in reported general payments places this provider in the 65th percentile of 2,237 adult health providers in Florida.

See all adult health providers in Florida

Medicare billing

Part B allowed, 2024
$29,310
Medicare patients
102
Services billed
298

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban24$17,046
JardianceEmpagliflozin11$10,053
XareltoRivaroxaban14$9,031
MyrbetriqMirabegron12$6,320
Levothyroxine Sodium91$956
LoperamideLoperamide Hcl17$779
Atorvastatin Calcium50$756
Rosuvastatin Calcium39$737
Pantoprazole Sodium37$673
Losartan Potassium32$614
Sertraline Hcl43$611
Amlodipine Besylate44$567
Mirtazapine31$507
Omeprazole27$475
Gabapentin25$426

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$53$17,04624 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,237 adult health providers in Florida.

Other adult health in Deland

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →